Clinical Trials of Antidepressants

1. Introduction
Martin M. Katz

2. Why Now the Need for a New Clinical Trials Model for Antidepressants?
Martin M. Katz

3. Reconceptualizing Depression, and the Current Scene on Dimensionality and the RDoC
Martin M. Katz

4. Aims and Basic Requirements of Clinical Trials: Conventional and Component-Specific Models
Martin M. Katz

5. Methods for Measuring the Components and the Profile of Drug Actions: The Multivantaged Approach
Martin M. Katz

6. Achieving the “Ideal” Clinical Trial: An Example of Applying the Merged Componential and Established Models
Martin M. Katz

7. Comparing the Component-Specific Model Directly with the Established Diagnosis-Specific Trial
Martin M. Katz

8. Prediction and Shortening the Clinical Trial: Further Advantages of the Component-Specific Model
Martin M. Katz

9. The Video Clinical Trial
Martin M. Katz

10. Conclusions
Martin M. Katz

Nyckelord: Psychology, Health Psychology